Benzodiazepines can stay in your system anywhere from a few days to several weeks, depending on which one you took and how it’s being tested for. Short-acting benzos like triazolam clear urine in about 3 to 5 days, while long-acting ones like diazepam (Valium) can be detected for up to 30 days. High doses of any benzodiazepine may produce positive urine results for as long as 6 weeks.
That wide range exists because benzodiazepines are not a single drug. They’re a class of more than a dozen medications, and they differ dramatically in how quickly your body breaks them down and clears them out.
Why the Type of Benzo Matters So Much
The most important factor in how long a benzodiazepine stays in your body is its elimination half-life, which is the time it takes for the concentration in your blood to drop by half. After roughly five half-lives, a drug is considered essentially cleared from your system. But those half-lives vary enormously from one benzo to another.
Short-acting benzodiazepines like triazolam (Halcion), midazolam (Versed), and temazepam (Restoril) have half-lives measured in hours. They’re designed to work quickly and wear off fast, which is why they’re commonly used for sleep or pre-surgery sedation. Your body processes and eliminates them relatively quickly.
Long-acting benzodiazepines tell a very different story. Diazepam (Valium), chlordiazepoxide (Librium), and flurazepam (Dalmane) have elimination half-lives ranging from 36 to 250 hours when you account for their active metabolites. That upper end is over 10 days for a single half-life, meaning full clearance could theoretically take weeks from your last dose.
Active Metabolites Extend the Timeline
When your liver breaks down certain benzodiazepines, it doesn’t just produce inactive waste. It creates new compounds called active metabolites that are themselves pharmacologically active, meaning they continue to have effects on your brain and body. Some of these metabolites have half-lives even longer than the original drug.
Diazepam is the classic example. Your body converts it into desmethyldiazepam, an active metabolite with a half-life that can stretch past 200 hours. So even after the diazepam itself is gone, its metabolite lingers, keeping the drug detectable and still exerting mild sedative effects. This is a major reason why diazepam can show up on tests for weeks.
Not all benzos behave this way. Lorazepam (Ativan) and oxazepam (Serax) are metabolized without producing active metabolites, so their clearance is more straightforward and predictable. If you’re trying to estimate how long a benzo will stay in your system, knowing whether it produces active metabolites is just as important as knowing its half-life.
Urine Test Detection Windows
Urine testing is by far the most common method for detecting benzodiazepines, whether for employment screening, probation, or medical monitoring. Standard immunoassay screens look for specific metabolites that benzos break down into, primarily oxazepam, alpha-hydroxyalprazolam, and 7-aminoclonazepam.
The general detection windows for urine are:
- Short-acting benzodiazepines (triazolam, midazolam): 3 to 5 days after last use
- Long-acting benzodiazepines (diazepam, chlordiazepoxide): up to 30 days after last use
- High-dose or chronic use (any benzodiazepine): up to 6 weeks
These are averages. Your personal timeline depends on factors like dose, how long you’ve been taking the medication, your metabolism, body fat percentage, age, and liver function. Benzodiazepines are fat-soluble, so they tend to accumulate in fatty tissue with repeated use and release slowly over time.
Blood, Saliva, and Hair Tests
Blood tests detect benzodiazepines for a shorter window than urine, typically 24 hours to a few days depending on the specific drug. Blood testing is more commonly used in emergency rooms or forensic settings than in routine screening because it reflects what’s currently active in your system rather than what was taken days ago.
Saliva testing has a similar window to blood, generally detecting use within the past 1 to 3 days. It’s becoming more common in roadside testing and some workplace programs because it’s harder to tamper with.
Hair follicle tests have the longest detection window of any method. Benzos can be detected in hair for up to 90 days, though hair testing for benzodiazepines is less reliable than it is for other drug classes. It’s not commonly used for routine screening but may appear in legal or forensic contexts.
How Chronic Use Changes Everything
If you’ve been taking a benzodiazepine daily for weeks or months, the clearance timeline is significantly longer than after a single dose. With repeated dosing, the drug and its metabolites accumulate in your body tissues. It takes much longer to fully eliminate a drug that has built up over time compared to clearing a one-time dose.
This accumulation effect is especially pronounced with long-acting benzos. Diazepam taken daily, for instance, never fully clears between doses. Each new dose adds to the existing reservoir. When you stop taking it, your body has to work through that entire backlog, which is why chronic diazepam users can test positive for 30 days or more.
Your individual metabolism also plays a significant role. People who metabolize drugs more slowly (due to genetics, age, or liver conditions) clear benzodiazepines at a measurably reduced rate. Research on genetic variation shows that some individuals have significantly lower plasma clearance of both diazepam and its primary metabolite compared to faster metabolizers. Older adults, people with liver disease, and those taking medications that compete for the same liver enzymes will generally fall on the longer end of every detection estimate.
Why Some Benzos Don’t Show Up on Standard Tests
Standard urine immunoassay screens are designed to detect the most common benzodiazepine metabolites, but they don’t catch all of them equally well. Certain benzos, particularly clonazepam (Klonopin) and lorazepam (Ativan), are notorious for producing false negatives on standard screens because they’re metabolized into compounds the test isn’t optimized to detect.
This doesn’t mean these drugs are undetectable. If a testing lab has reason to look specifically for clonazepam or lorazepam, it can run confirmatory testing that identifies specific metabolites with much greater accuracy. The initial screen is a broad net; confirmatory testing is a targeted search. So a negative result on a standard panel doesn’t necessarily mean a specific benzo is absent from your system.
The reverse can also happen. Some non-benzodiazepine medications can trigger false positives on immunoassay screens. If you’re taking a prescribed benzodiazepine and face a drug test, having documentation of your prescription is the simplest way to address a positive result.